Apr 11, 2023 07:00AM Verrica Pharmaceuticals Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference

May 25, 2022 11:26AM Needham & Company Downgrades Verrica Pharmaceuticals (VRCA) to Hold, Removes Price Target on "Uncertain Delay", Reiterates that "Ycanth Has a Bright Commercial Future"

May 25, 2022 11:25AM UPDATE: Needham & Company Downgrades Verrica Pharmaceuticals (VRCA) to Hold

Apr 7, 2022 07:30AM Verrica Pharmaceuticals Announces Participation in the 21st Annual Needham Virtual Healthcare Conference

Apr 7, 2022 07:30AM Verrica Pharmaceuticals Announces Participation in the 21st Annual Needham Virtual Healthcare Conference

Mar 3, 2022 06:16AM Verrica Pharmaceuticals (VRCA) PT Lowered to $18 at Needham & Company on Financing Overhang, Analyst Notes "Attractive Sales Potential" of Ycanth

Sep 21, 2021 05:47AM Verrica Pharmaceuticals (VRCA) PT Lowered to $20 at Needham & Company on 2nd CRL

Apr 6, 2021 07:30AM Verrica Pharmaceuticals Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

Apr 6, 2021 07:30AM Verrica Pharmaceuticals Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

Jun 30, 2020 06:03AM Verrica Pharmaceuticals (VRCA) PT Lowered to $17 at Needham & Company

Apr 9, 2020 04:05PM Verrica Pharmaceuticals to Participate in the 19th Annual Needham Virtual Healthcare Conference

Apr 9, 2020 04:05PM Verrica Pharmaceuticals to Participate in the 19th Annual Needham Virtual Healthcare Conference